Timothy C. Thompson
The University of Texas MD Anderson Cancer Center(US)Los Alamos National Laboratory(US)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, interferon and immune responses, Prostate Cancer Treatment and Research, Cancer, Lipids, and Metabolism, Caveolin-1 and cellular processes
Most-Cited Works
- → Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches(2013)861 cited
- → ELEVATED LEVELS OF CIRCULATING INTERLEUKIN-6 AND TRANSFORMING GROWTH FACTOR-beta 1 IN PATIENTS WITH METASTATIC PROSTATIC CARCINOMA(1999)382 cited
- → The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance(2019)374 cited
- → CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer(2007)346 cited
- Elevated expression of caveolin is associated with prostate and breast cancer.(1998)
- → In Situ Gene Therapy for Adenocarcinoma of the Prostate: A Phase I Clinical Trial(1999)304 cited
- → Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer